Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Sex hormones, especially estradiol, can change chicken feather shapes and colors.

Researchers identified genes and proteins that may influence wool thickness in sheep.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Higher levels of certain DNAs in blood may indicate hair follicle damage in alopecia areata patients.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

Stem cell niches support, regulate, and coordinate stem cell functions.

Prolactin affects hair growth cycles and can cause early hair follicle regression.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Older skin has higher cancer risk due to inflammation and stem cell issues.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Certain microRNAs are linked to various skin diseases and could be used to diagnose and treat these conditions.

Using neurohormones to control keratin can lead to new skin disease treatments.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Nellore cattle have genetic variations linked to their adaptation to tropical environments.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.

PCAT1 helps hair growth by controlling miR-329/Wnt10b.

Sulforaphane may help with hair growth by breaking down a hormone that causes hair loss.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

Chronic inflammatory skin diseases are caused by disrupted interactions between skin cells and immune cells.

Gray hair can potentially be reversed, leading to new treatments.